TargetGene Biotechnologies Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
TargetGene Biotechnologies General Information
Description
Provider of DNA editing services in living organisms. The company specializes in providing gene-specific DNA genome editing services in living organisms.
Contact Information
Website
WWW.targetgenebio.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
- Oppenheimer 10
- Floor 3
- Rehovot
- Israel
TargetGene Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TargetGene Biotechnologies Patents
TargetGene Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020373362-A1 | Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation | Pending | 28-Oct-2019 | 0000000000 | |
| CA-3159576-A1 | Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation | Pending | 28-Oct-2019 | 0000000000 | |
| EP-4051792-A1 | Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation | Pending | 28-Oct-2019 | 0000000000 | |
| EP-2790708-A1 | Compositions and methods for modifying a predetermined target nucleic acid sequence | Pending | 16-Dec-2011 | 000000000 | |
| EP-2790708-A4 | Compositions and methods for modifying a predetermined target nucleic acid sequence | Pending | 16-Dec-2011 | A61K38/00 |
TargetGene Biotechnologies Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yoel Shiboleth Ph.D | Co-Founder & Chief Executive Officer | ||
| Dan Weinthal Ph.D | Co-Founder & Chief Operating Officer |
TargetGene Biotechnologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
TargetGene Biotechnologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|